Condition: Focal Epilepsy · Sponsor: Praxis Precision Medicines
A multicenter, double-blind, randomized, placebo-controlled clinical trial to evaluate the efficacy and safety of vormatrigine in adults with focal seizures (POWER2)
This description comes directly from the study's public registry record.
Senior Medical Director Clinical Development · 773-939-6858 · clinicaltrials@praxismedicines.com
Always discuss trial participation with your own doctor first.
| Praxis Research Site | Miami, Florida, United States | Recruiting |
| Praxis Research Site | Miami Lakes, Florida, United States | Recruiting |
| Praxis Research Site | Naples, Florida, United States | Not Yet Recruiting |
| Praxis Research Site | Marlboro, New Jersey, United States | Recruiting |
| Praxis Research Site | Niagara Falls, New York, United States | Recruiting |
| Praxis Research Site | Raleigh, North Carolina, United States | Recruiting |
| Praxis Research Site | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07505004